Cargando...
Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...
Gardado en:
| Publicado en: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308315/ https://ncbi.nlm.nih.gov/pubmed/30622514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00777 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|